Patient Information Leaflet
Azzavix 1000 mg Gastro-Resistant Tablets
mesalazine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Azzavix gastro-resistant tablets contain 1000 mg of the active substance mesalazine (also known as 5-aminosalicylic acid), which belongs to the group of medicines called intestinal anti-inflammatory agents.
Azzavix is indicated for the treatment of ulcerative colitis, an inflammatory disease of the intestine.
Do not take Azzavix
Warnings and precautions
Consult your doctor before starting treatment with Azzavix
If you experience severe headache or recurrent headache, vision changes, or ringing or buzzing in the ears, contact your doctor immediately.
In case of appearance of any allergic manifestation (e.g., skin rash, itching) or cramps, abdominal pain, severe headache, and fever during the course of treatment, do not take any more tablets and inform your doctor immediately.
Before and during treatment, your doctor may want to perform regular blood and urine tests to check the functioning of your liver, kidneys, blood, and lungs.
Kidney stones may occur with the use of mesalazine. The symptoms include pain in the sides of the abdomen and blood in the urine. Make sure to drink a sufficient amount of liquid during treatment with mesalazine.
Severe skin rashes, such as drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SSJ), and toxic epidermal necrolysis (TEN), have been observed with mesalazine treatment. Stop taking mesalazine and seek medical attention immediately if you observe any of the symptoms related to these severe skin reactions described in section 4.
Mesalazine may cause a discoloration of the urine to a reddish-brown color after contact with sodium hypochlorite bleach in the toilet water. This is a chemical reaction between mesalazine and bleach and is harmless.
Children and adolescents
Information on safety in the use of this medicine in children and adolescents is limited.
Do not administer to children under 5 years of age.
Other medicines and Azzavix 1000 mg Gastro-Resistant Tablets
In general, you can continue treatment with other medicines while taking Azzavix. However, inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine, including those obtained without a prescription.
Azzavix may interact with some medicines if taken at the same time.
In particular:
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
There is limited experience with the use of mesalazine during pregnancy and breast-feeding. The newborn may develop allergic reactions after breast-feeding, such as diarrhea. If the newborn develops diarrhea, breast-feeding should be discontinued.
The use of Azzavix is not recommended during pregnancy or breast-feeding unless your doctor advises you otherwise.
Driving and using machines
No adverse effects of Azzavix on the ability to drive or use machines have been reported.
Azzavix 1000 mg Gastro-Resistant Tablets contain sodium
This medicine contains 98 mg of sodium (main component of table/cooking salt) in each gastro-resistant tablet. This is equivalent to 5% of the maximum daily recommended sodium intake for an adult.
Consult your doctor or pharmacist if you need to take 4 or more gastro-resistant tablets daily for a prolonged period, especially if you have been advised to follow a low-salt diet.
Follow exactly the administration instructions of this medicine indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
Your doctor will indicate the duration of your treatment with this medicine. Do not stop treatment before, even if you feel better, as symptoms may return if treatment is stopped too soon.
Strictly follow the treatment according to your doctor's instructions, both in the acute inflammatory phase and in the maintenance time established.
The recommended dose in adults is:
To treat an acute episode of colitis,your doctor will normally prescribe a dose between 1.5 (one 1000 mg tablet and one 500 mg tablet) and 4 grams (four 1000 mg tablets) of mesalazine per day, which can be administered in one or several doses.
To help prevent further episodes,your doctor may prescribe a dose between 1.5 (one 1000 mg tablet and one 500 mg tablet) and 3 grams (three 1000 mg tablets) of mesalazine per day, which can be administered in one or several doses.
Azzavix 1000 mg Gastro-Resistant Tablets should be taken orally.
The gastro-resistant tablets should be taken before meals, swallowing the tablet whole with the help of liquid. Do not divide, chew, or crush.
In both cases, it may be necessary to use the 500 mg tablets of Azzavix to provide the dose that best suits you.
Use in children and adolescents
The administration of Azzavix is not recommended for children and adolescents under 18 years of age due to the lack of data on its safety and efficacy. Do not administer to children under 5 years of age.
Use in elderly patients
The use of Azzavix in elderly patients should be done with caution and limited to those patients with normal renal function.
If you take more Azzavix 1000 mg Gastro-Resistant Tablets than you should
Consult your doctor if you have taken more than prescribed. In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken. It is recommended to take the package and the leaflet of the medicine to the healthcare professional.
Consult your doctor if you have taken more than prescribed.
If you forget to take Azzavix 1000 mg Gastro-Resistant Tablets
Do not take a double dose to make up for the forgotten dose.
If you stop taking Azzavix 1000 mg Gastro-Resistant Tablets
It is important that you take Azzavix gastro-resistant tablets every day, even when you do not have symptoms of ulcerative colitis. Always finish the treatment that has been prescribed to you.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
All medicines can cause allergic reactions, although serious allergic reactions are very rare. If you get any of the following symptoms after taking this medicine, stop taking this medicine and contact your doctor immediately:
If you experience fever or irritation of the throat or mouth, stop using this medicine and contact your doctor immediately. These symptoms may be due, very rarely, to a decrease in the number of white blood cells in the blood (a condition called agranulocytosis).
Serious side effects:
Stop taking mesalazine and seek medical attention immediately if you experience any of the following symptoms:
The following side effects have also been reported in patients using mesalazine:
Rare side effects(may affect up to 1 in 1,000 people)
Very rare side effects(may affect less than 1 in 10,000 people)
Side effects of unknown frequency(cannot be estimated from the available data).
severe skin reactions: drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SSJ), and toxic epidermal necrolysis (TEN).
Photosensitivity
More severe reactions have been reported in patients with pre-existing skin conditions, such as atopic dermatitis and atopic eczema.
If these symptoms continue or become more severe, consult your doctor.
Reporting of side effects:
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require special storage conditions.
Do not use this medicine after the expiry date which is stated on the package after EXP. The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Return the packages and medicines you no longer need to the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packages and medicines no longer needed. This will help protect the environment.
Composition of Azzavix 1000 mg Gastro-Resistant Tablets
Appearance and packaging of the product
This medicine is marketed in PVC/PVDC-Aluminum blisters packaged in cardboard boxes containing 60 or 100 tablets.
Only some pack sizes may be marketed.
The tablets are oblong, orange-colored, film-coated tablets.
Marketing authorization holder
Faes Farma, S.A.
Autonomia Etorbidea, 10
48940 Leioa (Bizkaia)
Spain
Manufacturer
Faes Farma, S.A.
Maximo Agirre Kalea, 14
48940 Leioa (Bizkaia)
Spain
Date of last revision of this leaflet: January 2023